JamesAustinTalcottMD

Oncology • Yakima, WA

Genitourinary Oncology, Hematologic Oncology

Professor, Medicine, Albert Einstein College of Medicine of Yeshiva University

Join to view full profile

Dr. Talcott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Talcott's full profile

Already have an account?

Office
808 N 39th Ave
Yakima, WA 98902
Phone+1 509-574-3400

Fax+1 509-574-3464
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1987
University of WashingtonChief Residency, Internal Medicine, 1983 - 1984
University of WashingtonResidency, Internal Medicine, 1981 - 1983
University of WashingtonInternship, Internal Medicine, 1980 - 1981
Yale School of MedicineClass of 1980

Certifications & Licensure

KY State Medical License 2022 - 2024
NY State Medical License 2011 - 2024
MN State Medical License 2021 - 2023
AR State Medical License 2023 - 2023
WA State Medical License 1981 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Reply to A. K. Tewari et al.
James A. Talcott, Katherine S. Virgo> ;Journal of Clinical Oncology. 2021 May 14
54 citations
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
, , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2021 Jan 26
21 citations
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.
Joanne W. Jang, Michael Drumm, Jason A. Efstathiou, Jonathan J. Paly, Andrzej Niemierko, Marek Ancukiewicz, James A. Talcott, Jack A. Clark, Anthony L. Zietman> ;Cancer Medicine. 2017 May 31
17 citations
The Health Effects of Masculine Self-Esteem Following Treatment for Localized Prostate Cancer Among Gay Men
Donald Allensworth-Davies, James A. Talcott, Timothy Heeren, Brian de Vries, Thomas O. Blank, Jack A. Clark> ;LGBT Health. 2015 Dec 24
1 citations
In the Clinic. Prostate Cancer.
James A. Talcott> ;Annals of Internal Medicine. 2015 Dec 1
23 citations
Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.
Bryce B. Reeve, Ronald C. Chen, Dominic T. Moore, Allison M. Deal, Deborah S. Usinger, Jessica C. Lyons, James A. Talcott> ;BJU International. 2014 Dec 1
Primary care physician-led health reform.
Talcott, J. A.> ;JAMA. 2014 Oct 08
2 citations
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.
, , , , , , , , , , , , , , , > ;Urologic Oncology. 2014 Jan 1
13 citations
Using patient-reported outcomes to assess and improve prostate cancer brachytherapy.
James A. Talcott, Judith Manola, Ronald C. Chen, Jack A. Clark, Irving D. Kaplan, Anthony V. D'Amico, Anthony L. Zietman> ;BJU International. 2014 Oct 1
68 citations
Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer
Phillip J. Gray, Jonathan J. Paly, Beow Y. Yeap, Martin G. Sanda, Howard M. Sandler, Jeff M. Michalski, James A. Talcott, John J. Coen, Daniel A. Hamstra, William U. S...> ;Cancer. 2013 May 1
25 citations
Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer
John J. Coen, Jonathan J. Paly, Andrzej Niemierko, Elizabeth A. Weyman, Anita Rodrigues, William U. Shipley, Anthony L. Zietman, James A. Talcott> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Feb 1
38 citations
Costs of Home Versus Inpatient Treatment for Fever and Neutropenia: Analysis of a Multicenter Randomized Trial
Ann Hendricks, Elizabeth T. Loggers, James A. Talcott> ;Journal of Clinical Oncology. 2011 Oct 20
40 citations
Safety of Early Discharge for Low-Risk Patients With Febrile Neutropenia: A Multicenter Randomized Controlled Trial
James A. Talcott, Beow Y. Yeap, Jack A. Clark, Robert D. Siegel, Elizabeth Loggers, Charles Lu, Paul A. Godley> ;Journal of Clinical Oncology. 2011 Oct 20
33 citations
Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for ...
Paul L. Nguyen, Ronald C. Chen, Karen E. Hoffman, Alexei Trofimov, Jason A. Efstathiou, John J. Coen, William U. Shipley, Anthony L. Zietman, James A. Talcott> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Nov 15
4 citations
Race, healthcare access and physician trust among prostate cancer patients
Young Kyung Do, William R. Carpenter, Pamela Spain, Jack A. Clark, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, James A. Talcott, Paul A. Godley> ;The Journal of Urology. 2010 Nov 1
22 citations
Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer.
Ronald C. Chen, Harvey J. Mamon, Yu-Hui Chen, Rebecca Gelman, W. Warren Suh, James A. Talcott, Jeffrey W. Clark, Theodore S. Hong> ;Cancer. 2010 Apr 15
72 citations
Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.
James A. Talcott, Carl J. Rossi, William U. Shipley, Jack A. Clark, Jerry D. Slater, Andrzej Niemierko, Anthony L. Zietman> ;JAMA. 2010 Mar 17
41 citations
Race, healthcare access and physician trust among prostate cancer patients.
Young Kyung Do, William R. Carpenter, Pamela Spain, Jack A. Clark, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, James A. Talcott, Paul A. Godley> ;Cancer Causes & Control. 2010 Jan 1
79 citations
Racial Differences in Trust and Regular Source of Patient Care and the Implications for Prostate Cancer Screening Use
William R. Carpenter, Paul A. Godley, Jack A. Clark, James A. Talcott, Timothy J Finnegan, Merle H. Mishel, Jeannette T. Bensen, Walter Rayford, L. Joseph Su, Elizabet...> ;Cancer. 2009 Nov 1
152 citations
Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexu...
Ronald C. Chen, Jack A. Clark, James A. Talcott> ;Journal of Clinical Oncology. 2009 Aug 20
19 citations
Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.
Pamela Spain, William R. Carpenter, James A. Talcott, Jack A. Clark, Young Kyung Do, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, Paul A. Godley> ;Cancer. 2008 Oct 15
10 citations
Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity.
Joshua H. Petit, Clifford Gluck, W. S. Kiger, D. Laury Henry, Carol Karasiewicz, James A. Talcott, Solomon Berg, Edward J. Holupka, Irving D. Kaplan> ;Urologic Oncology. 2008 Jul 1
104 citations
Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia
Linda S. Elting, Charles Lu, Carmelita P Escalante, Sharon H. Giordano, Jonathan C. Trent, Catherine D. Cooksley, Elenir B. C. Avritscher, Ya Chen Tina Shih, Joe Ensor...> ;Journal of Clinical Oncology. 2008 Feb 1
38 citations
Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account?
Ronald C. Chen, Jack A. Clark, Judith Manola, James A. Talcott> ;Cancer. 2008 Jan 1
7 citations
Measuring perceived effects of drinking an extract of basidiomycetes Agaricus blazei murill: A survey of Japanese consumers with cancer
James A. Talcott, Jack A. Clark, Insu P Lee> ;BMC Complementary and Alternative Medicine. 2007 Oct 29
Join now to see all

Press Mentions

Advanced Treatment-Validation Technology Set to Improve Cancer Treatment ResultsJuly 20th, 2022

Professional Memberships

American Society of Clinical Oncology - ASCO
Member